Jane Street Group, LLC Royalty Pharma PLC Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $2.01 Million - $2.29 Million	78,300 New	78,300 $2.22 Million
Q1 2022 May 17, 2022	SELL	$37.46 - $42.44 $4.5 Million - $5.1 Million	-120,100 Reduced 35.51%	218,100 $8.5 Million
Q4 2021 Feb 15, 2022	SELL	$35.17 - $42.48 $2.61 Million - $3.15 Million	-74,100 Reduced 17.97%	338,200 $13.5 Million
Q3 2021 Nov 16, 2021	BUY	$36.14 - $42.24 $10.6 Million - $12.4 Million	292,900 Added 245.31%	412,300 $14.9 Million
Q2 2021 Aug 16, 2021	SELL	$39.85 - $46.63 $15 Million - $17.6 Million	-377,200 Reduced 75.96%	119,400 $4.89 Million
Q1 2021 May 18, 2021	BUY	$42.34 - $52.82 $15.1 Million - $18.8 Million	356,100 Added 253.45%	496,600 $21.7 Million
Q4 2020 Feb 17, 2021	BUY	$36.12 - $50.05 $4.59 Million - $6.36 Million	127,100 Added 948.51%	140,500 $7.03 Million
Q3 2020 Nov 17, 2020	BUY	$38.56 - $48.36 $516,704 - $648,024	13,400 New	13,400 $564,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.